Animal-to-human organ transplants promise a future where survival no longer depends on another person’s death.
Using CRISPR, multiomics, and machine learning, molecular biologist Larschan unravels the mysteries of the X chromosome.
Morning Overview on MSN
RNA-based therapy reaches proof-of-concept for autism-related gene mutations in preclinical models
A single injection into the bloodstream of a mouse corrected a mutation linked to autism in neurons throughout the brain and ...
The ethics of using safe gene therapies to improve the health and cognition of Down syndrome children and adults.
Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that causes Down syndrome (DS). Down syndrome is a genetic condition caused by an ...
Prime Minister Mark Carney has hailed the impending arrival of Chinese-made electric vehicles as a way to bring affordable cars to the country and as a way “to protect and create new auto ...
Scientists are laying the groundwork for treating one of the most common genetic conditions in humans. Research out today highlights a promising new approach to Down syndrome, also known as trisomy 21 ...
CRISPR Therapeutics plans to post clinical trial updates for multiple candidates this year. The company's stock could jump if it can impress the market. Investors should keep in mind that this biotech ...
A modified version of CRISPR-Cas9 has enabled, for the first time, the efficient integration of a large transgene capable of inactivating entire chromosomes into one of the three copies of chromosome ...
There have been reports that Chinese electric vehicle maker BYD Co. Ltd. is interested in setting up a dealership network in Canada. (Credit: Chris Ratcliffe/Bloomberg files) Prime Minister Mark ...
CRISPR Therapeutics is still losing money, but it has an expanding pipeline. The biotech is seeing growing sales from its one product, Casgevy. It also has other promising drug candidates in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results